Gawęcki Wojciech, Karlik Michał, Borucki Łukasz, Szyfter-Harris Joanna, Wróbel Maciej
Department of Otolaryngology and Laryngological Oncology, Poznań University of Medical Sciences, Poznań, Poland.
Department of Phoniatrics and Audiology, Poznań University of Medical Sciences, Poznań, Poland.
Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4175-4183. doi: 10.1007/s00405-016-4107-1. Epub 2016 May 31.
The objective of the study was to analyse and present the surgical management strategy for major skin flap complications (MSFC) after cochlear implantations. Patients fitted with a titanium-silicone-coated implant of the same kind, operated on between 1994 and 2013 with a standardised procedure (1076 medical charts) were analysed. Analysis aimed to identify and study individuals with skin problems related to the cochlear implant treatment, i.e. requiring surgical treatment in hospital defined as MSFC and focused on incidence, risk factors and treatment of MSFC. MSFC were diagnosed in 1.76 % of patients: 2.06 % of children and 1.35 % of adults, 2.43 % after implantation with a long "C"-shaped incision and 1.28 % after short retroauricular incision. Registered risk factors included head trauma, acute otitis media, poor hygiene in children, and general comorbidities in adults. The primary intervention was dependent on skin complication severity and included revision surgery with wound closure over an implant (52.6 %) and revision surgery with explantation (47.4 %). Revision surgery without explantation was successful in 40 % and the most effective approach was debridement with a two-layer rotational flap. Explantation led to ultimate wound healing in all cases. Major skin flap complications after cochlear implantation are rare, but their treatment is complex and difficult. Revision surgery with resection of infected tissue, formation of a rotational two-layer flap preceded and supplemented by intensive targeted antibiotic therapy can be effective and should be the first treatment option. Spontaneous implant explantation, abscess formation or unsuccessful primary treatment necessitate implant removal as the ultimate solution.
该研究的目的是分析并呈现人工耳蜗植入术后主要皮瓣并发症(MSFC)的手术管理策略。对1994年至2013年间采用标准化手术(1076份病历)植入同类型钛硅涂层植入物的患者进行了分析。分析旨在识别和研究与人工耳蜗治疗相关的皮肤问题患者,即在医院需要手术治疗的定义为MSFC,并关注MSFC的发生率、危险因素和治疗方法。1.76%的患者被诊断为MSFC:儿童为2.06%,成人为1.35%;长“C”形切口植入后为2.43%,耳后短切口植入后为1.28%。登记的危险因素包括头部外伤、急性中耳炎、儿童卫生条件差以及成人的一般合并症。主要干预措施取决于皮肤并发症的严重程度,包括在植入物上进行伤口闭合的翻修手术(52.6%)和取出植入物的翻修手术(47.4%)。未取出植入物的翻修手术成功率为40%,最有效的方法是采用双层旋转皮瓣进行清创。取出植入物在所有病例中均导致最终伤口愈合。人工耳蜗植入术后的主要皮瓣并发症很少见,但其治疗复杂且困难。切除感染组织、形成旋转双层皮瓣并辅以强化靶向抗生素治疗的翻修手术可能有效,应作为首选治疗方案。自发的植入物取出、脓肿形成或初次治疗失败需要取出植入物作为最终解决方案。